Zobrazeno 1 - 8
of 8
pro vyhledávání: '"E. Raya-Άlvarez"'
Autor:
M.J. Soto Pino, Mά Ferrer González, I. Notario Ferreira, R. Cáliz Cáliz, A González Utrilla, P Morales Garrido, E. Raya Άlvarez, C Caro Hernández, L. Pérez Albaladejo, I Añόn Oñate
Publikováno v:
Abstracts Accepted for Publication.
Background Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS) and Thrombophilia are associated with considerable pregnancy-related morbidity. Multidisciplinary teams allows the application of an experienced protocol to monitor and tr
Autor:
M. Lόpez-Sidro, R. Durán Ogalla, E. Raya-Άlvarez, S. Bandrés Ciga, F. Vives Montero, J. Salvatierra Ossorio, A. García Sánchez
Publikováno v:
Annals of the Rheumatic Diseases. 73:480.3-481
Background The development of biological therapies which block the tumor necrosis factor alfa (TNFα) has revolutionized the treatment of various inflammatory diseases such as rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthr
Autor:
Eva Tomero, B. Hernández, A. Olivé, Mercedes Freire, F.J. Lόpez-Longo, Rosario García-Vicuña, María José Galindo, Ana Sánchez-Atrio, Sara Manrique-Arija, I. Villa, E. Úcar, A. Zea, Antonio Fernández-Nebro, Patricia Carreira, Mónica Fernández-Castro, JL Marenco, R. Martínez Pérez, C.M. Romero-Barco, V. Rodríguez-García, Javier Narváez, Víctor M. Martínez-Taboada, J.M. Pego, Luis Carreño, L. Nieves-Martín, E. Raya-Άlvarez, J.J. Pérez-Venegas, Iñigo Rúa-Figueroa
Publikováno v:
Annals of the Rheumatic Diseases. 71:674.9-674
Objectives To investigate lipidic changes that occurs with Rituximab(RTX) in refractory SLE-patients. Methods Multicenter, retrospective, longitudinal study. All SLE-patients from LESIMAB study with basic lipid data at baseline and 6±3 months after
Autor:
E. Raya Άlvarez, Juan Salvatierra, J.L. Rosales Alexander, J. Cantero Hinojosa, C. Magro Checa
Publikováno v:
Annals of the Rheumatic Diseases. 71:689.14-689
Background The Spondyloarthritis International Society (ASAS) published a new measurement tool to help in the assessment of disease activity in Ankylosing Spondylitis (AS) patients and as an instrument to assess treatment response in spondyloarthriti
Autor:
Juan Salvatierra, J.L. Rosales-Alexander, J. Cantero-Hinojosa, César Magro-Checa, E. Raya-Άlvarez, J. González-Domínguez
Publikováno v:
Annals of the Rheumatic Diseases. 71:571.2-571
Background Stratifying cardiovascular risk using risk charts is central to decision-making on treatment to prevent cardiovascular disease. EULAR task force on cardiovascular (CV) risk management in patients (pts) with inflammatory arthritis recommend
Autor:
J. Salvatierra, J. Cantero-Hinojosa, J.L. Rosales-Alexander, R. Sánchez-Parera, E. Raya-Άlvarez, César Magro-Checa, S. Montes-García
Publikováno v:
Annals of the Rheumatic Diseases. 71:407.4-408
Background EULAR task force recommendations in the cardiovascular (CV) risk were published in 2010. EULAR recommends the use of the SCORE when no local guidelines are available. In our country, two charts have been calibrated and are widely used to c
Autor:
J.L. Rosales-Alexander, S. Arias-Santiago, J. Cantero-Hinojosa, J. Orgaz-Molina, Juan Salvatierra, César Magro-Checa, Jose Carlos Ruiz-Carrascosa, E. Raya-Άlvarez
Publikováno v:
Annals of the Rheumatic Diseases. 71:572.1-572
Background Patients with psoriatic arthritis (PsA) and cutaneous psoriasis alone (PsC) are known to have an increased risk of Cardiovascular (CV) disease. The increase of Carotid Intima-Media Thickness (cIMT) in patients with PsA and PsC has been dem
Autor:
Juan Salvatierra, J.L. Rosales-Alexander, J. Cantero-Hinojosa, J. Orgaz-Molina, E. Raya-Άlvarez, Jose Carlos Ruiz-Carrascosa, S. Arias-Santiago, César Magro-Checa
Publikováno v:
Annals of the Rheumatic Diseases. 71:572.2-572
Background Patients with psoriatic arthritis (PsA) and with moderate to severe chronic plaque psoriasis (PS) have a higher prevalence of cardiovascular (CV) risk factors and atherosclerosis. The Ankle-Brachial pressure Index (ABPI) at rest, a non-inv